
MD Research & Development
Working to increase sensitivity and accuracy in cancer treatment.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
$52.0k Valuation: $3.0m | Seed | ||
Total Funding | 000k |
Related Content
MD Research Development, founded in 2017, is a leader in the field of Radiation Oncology. The company is dedicated to pioneering innovative solutions that drive progress and improve lives. MD Research Development serves healthcare providers and institutions that require advanced radiation oncology solutions. Operating in the medical technology market, the company focuses on developing cutting-edge treatments and technologies to enhance patient care and outcomes. The business model revolves around research and development, product innovation, and strategic partnerships with healthcare organizations. Revenue is generated through the sale of proprietary medical devices, licensing of technology, and consulting services. The company emphasizes excellence and integrity in all its operations, ensuring that its solutions meet the highest standards of quality and efficacy.
Keywords: Radiation Oncology, Medical Technology, Healthcare Providers, Innovative Solutions, Patient Care, Research and Development, Product Innovation, Strategic Partnerships, Medical Devices, Consulting Services.